BD trial for breast implant revision surgery passes enrollment milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. META
3. LGND
4. SPY
5. PSKY
6. MONRY
7. DGX
8. PNR
9. TDY
10. ANF

Go back to BD trial for breast implant revision surgery passes enrollment milestone
Becton Dickinson (NYSE: BDX) Delayed: 181.57 +0.87 (0.48%)
Previous Close $180.70    52 Week High $181.76 
Open $182.20    52 Week Low $129.50 
Day High $182.83    P/E 38.71 
Day Low $181.00    EPS $4.69 
Volume 27,274